Literature DB >> 25639770

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Howard M Shulman1, Diana M Cardona2, Joel K Greenson3, Sangeeta Hingorani4, Thomas Horn5, Elisabeth Huber6, Andreas Kreft7, Thomas Longerich8, Thomas Morton9, David Myerson10, Victor G Prieto11, Avi Rosenberg12, Nathaniel Treister13, Kay Washington14, Mirjana Ziemer15, Steven Z Pavletic16, Stephanie J Lee1, Mary E D Flowers1, Kirk R Schultz17, Madan Jagasia18, Paul J Martin1, Georgia B Vogelsang19, David E Kleiner20.   

Abstract

The 2005 National Institute of Health (NIH) Consensus Conference outlined histopathological diagnostic criteria for the major organ systems affected by both acute and chronic graft-versus-host disease (GVHD). The 2014 Consensus Conference led to this updated document with new information from histopathological studies of GVHD in the gut, liver, skin, and oral mucosa and an expanded discussion of GVHD in the lungs and kidneys. The recommendations for final histological diagnostic categories have been simplified from 4 categories to 3: no GVHD, possible GVHD, and likely GVHD, based on better reproducibility achieved by combining the previous categories of "consistent with GVHD" and "definite GVHD" into the single category of "likely GVHD." Issues remain in the histopathological characterization of GVHD, particularly with respect to the threshold of histological changes required for diagnostic certainty. Guidance is provided for the incorporation of biopsy information into prospective clinical studies of GVHD, particularly with respect to biomarker validation. Published by Elsevier Inc.

Entities:  

Keywords:  Allogeneic hematopoietic cell transplantation; Chronic graft-versus-host disease; Consensus; Diagnosis; Histology; Pathology

Mesh:

Substances:

Year:  2015        PMID: 25639770      PMCID: PMC4359636          DOI: 10.1016/j.bbmt.2014.12.031

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  132 in total

1.  Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal.

Authors:  C Vassallo; V Brazzelli; P E Alessandrino; M Varettoni; M Ardigò; M Lazzarino; G Borroni
Journal:  Br J Dermatol       Date:  2004-09       Impact factor: 9.302

2.  Skin involvement in scleroderma--where histological and clinical scores meet.

Authors:  F Verrecchia; J Laboureau; O Verola; N Roos; R Porcher; P Bruneval; M Ertault; K Tiev; L Michel; A Mauviel; D Farge
Journal:  Rheumatology (Oxford)       Date:  2007-01-25       Impact factor: 7.580

3.  High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.

Authors:  Richard A Nash; Peter A McSweeney; Leslie J Crofford; Muneer Abidi; Chien-Shing Chen; J David Godwin; Theodore A Gooley; Leona Holmberg; Gretchen Henstorf; C Fred LeMaistre; Maureen D Mayes; Kevin T McDonagh; Bernadette McLaughlin; Jerry A Molitor; J Lee Nelson; Howard Shulman; Rainer Storb; Federico Viganego; Mark H Wener; James R Seibold; Keith M Sullivan; Daniel E Furst
Journal:  Blood       Date:  2007-04-23       Impact factor: 22.113

4.  Grover's Disease after Bone Marrow Transplantation.

Authors:  Javier Bolaños-Meade; Viki Anders; Joshua Wisell; Evan R Farmer; Georgia B Vogelsang
Journal:  Biol Blood Marrow Transplant       Date:  2007-09       Impact factor: 5.742

5.  Diagnosis of gastrointestinal graft-versus-host disease--is rectal biopsy enough?

Authors:  Andreas Nydegger; Anthony Graeme Catto-Smith; Karin Tiedemann; Winita Hardikar
Journal:  Pediatr Blood Cancer       Date:  2007-05       Impact factor: 3.167

6.  Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation.

Authors:  Somaya El-Seisi; Rekha Gupta; Catherine M Clase; Donna L Forrest; Mirko Milandinovic; Stephen Couban
Journal:  Biol Blood Marrow Transplant       Date:  2003-11       Impact factor: 5.742

7.  Histopathology of graft versus host disease of the liver.

Authors:  A Quaglia; R Duarte; D Patch; K Ngianga-Bakwin; A P Dhillon
Journal:  Histopathology       Date:  2007-05       Impact factor: 5.087

8.  Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment.

Authors:  Lisa B Spiryda; Marc R Laufer; Robert J Soiffer; Joseph A Antin
Journal:  Biol Blood Marrow Transplant       Date:  2003-12       Impact factor: 5.742

Review 9.  Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?

Authors:  Kirsten Brukamp; Alden M Doyle; Roy D Bloom; Nancy Bunin; John E Tomaszewski; Borut Cizman
Journal:  Clin J Am Soc Nephrol       Date:  2006-03-15       Impact factor: 8.237

10.  Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients.

Authors:  Vinod B Shidham; Chung-Che Chang; Ganesh Shidham; Farrukh Ghazala; Paul F Lindholm; Bal Kampalath; Varghese George; Richard Komorowski
Journal:  BMC Gastroenterol       Date:  2003-03-27       Impact factor: 3.067

View more
  60 in total

1.  Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies.

Authors:  Seungwon An; Ilangovan Raju; Bayasgalan Surenkhuu; Ji-Eun Kwon; Shilpa Gulati; Muge Karaman; Anubhav Pradeep; Satyabrata Sinha; Christine Mun; Sandeep Jain
Journal:  Ocul Surf       Date:  2019-04-06       Impact factor: 5.033

2.  Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.

Authors:  Lee Gazourian; Laura Spring; Emily Meserve; David Hwang; Alejandro A Diaz; Samuel Y Ash; Vincent T Ho; Lynette M Sholl; George R Washko
Journal:  Biol Blood Marrow Transplant       Date:  2017-06-28       Impact factor: 5.742

Review 3.  Cytokine mediators of chronic graft-versus-host disease.

Authors:  Kelli Pa MacDonald; Bruce R Blazar; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2017-06-30       Impact factor: 14.808

4.  Ocular instillation of vitamin A-coupled liposomes containing HSP47 siRNA ameliorates dry eye syndrome in chronic GVHD.

Authors:  Hiroyuki Ohigashi; Daigo Hashimoto; Eiko Hayase; Shuichiro Takahashi; Takahide Ara; Tomohiro Yamakawa; Junichi Sugita; Masahiro Onozawa; Masao Nakagawa; Takanori Teshima
Journal:  Blood Adv       Date:  2019-04-09

5.  Is there really a specific graft-versus-leukaemia effect?

Authors:  R P Gale; E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2016-07-11       Impact factor: 5.483

Review 6.  Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Ema Prenc; Drazen Pulanic; Maja Pucic-Bakovic; Marija Pezer; Lana Desnica; Radovan Vrhovac; Damir Nemet; Steven Z Pavletic
Journal:  Biochim Biophys Acta       Date:  2016-02-26

7.  Biomarkers in chronic graft-versus-host disease: quo vadis?

Authors:  D Wolff; H Greinix; S J Lee; T Gooley; S Paczesny; S Pavletic; F Hakim; F Malard; M Jagasia; A Lawitschka; J A Hansen; D Pulanic; E Holler; A Dickinson; E Weissinger; M Edinger; S Sarantopoulos; K R Schultz
Journal:  Bone Marrow Transplant       Date:  2018-01-24       Impact factor: 5.483

Review 8.  Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation.

Authors:  Erden Atilla; Pınar Ataca Atilla; Güldane Cengiz Seval; Mehmet Bektaş; Taner Demirer
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

Review 9.  Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

Authors:  Kelli P A MacDonald; Geoffrey R Hill; Bruce R Blazar
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

Review 10.  Classification systems for chronic graft-versus-host disease.

Authors:  Stephanie J Lee
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.